Sandoz, a global generic pharmaceutical company and key part of the Norvatis group, has vowed to continue to ensure that Nigerians and the global community have access to quality medicines.
Country Head of the company, Adedeji Idowu, made the pledge in his opening remarks at a colourful ceremony held at Planet 1, Maryland, Ikeja, Lagos, recently, to introduce Candesartan, a product, he said was introduced to address the unmet needs in the management of cardiovascular diseases, particularly hypertension, left ventricular hypertrophy and heart failure.
The memorable event, chaired by Prof. Wale Oke, chief medical director ofthe Lagos State University Teaching Hospital (LASUTH), was also graced by other leading health professionals, among whom were Dr A. C. Mbakwem, a consultant physician and cardiologist from the Lagos University Teaching Hospital (LUTH); DrDike Ojji, consultant physician and cardiologist, University of Abuja Teaching Hospital (UATH); and DrO. B. Familoni, also a consultant physician and cardiologist from the Olabisi Onabanjo University Teaching Hospital (OOUTH).
The health experts gave educative talks on hypertension and currentmethods of managing it, as well as the use of Candesartan in the management of hypertension and left ventricular hypertrophy.
The Sandoz Country Head said Norvatis and Sandoz were ready to bridge the access divide in the ability of millions of patients to afford medications they have been prescribed, without compromising product quality at a much reduced cost.
He added that the company was determined to ensure access to quality medicines for the greatest number of people.
In his closing remarks, Prof. Wale Oke, reiterated the opinions of the speakers on how crucial it is for physicians to embrace a holistic approach in the management of hypertension and its attendant consequences and co-morbidities.
The highlight of the occasion was the official unveiling of Sandoz Candesartan by the dignitaries at the occasion.